AN ACT REQUIRING BRAND NAME PRESCRIPTION DRUG MANUFACTURERS TO PROVIDE SAMPLES OF BRAND NAME DRUGS TO GENERIC PRESCRIPTION DRUG MANUFACTURERS. To promote competition in the prescription drug market by allowing developers of generic drugs and biosimilar products to obtain reference samples.
AN ACT CONCERNING FUNDING FOR NONPROFIT COMMUNITY PROVIDERS. To provide financial support for nonprofit community providers that face increased demand for services.
If a hospital or health system charges a facility fee utilizing a current procedural terminology evaluation and management (CPT E/M) code or assessment and management (CPT A/M) code for outpatient services provided at a hospital-based facility where a professional fee is also expected to be charged, the hospital or health system shall provide the patient with a written notice that includes the amount of the patient's potential financial liability, including any facility fee likely to be charged, and, where professional medical services are provided by an affiliated provider, any professional fee likely to be [...]
To extend the expansion of telehealth provisions in the state to June 30, 2024.
To prohibit hospitals from charging facility fees on and off a hospital campus for telehealth services.
To (1) require certificate of need approval before breaking ground, (2) require the State of Connecticut Health and Educational Facilities Authority to review certain information before issuing certain bonds, (3) increase the application fee for certificates of need, and (4) require a study concerning certificates of need.
This bill expands the Office of Health Strategy’s (OHS) duties to include, among other things, setting annual health care cost growth benchmarks, health care quality benchmarks, and primary care spending targets. When developing these benchmarks and spending targets, the executive director may hold informational public hearings and consider certain specified information. The task force must study and make recommendations on instituting a price increase cap tied to the cost growth benchmark for consolidations, setting standards to measure quality due to a consolidation, the attorney general’s authority to stop activities as the result of a [...]